Lisbon, Portugal : 18 - 20 May 2020
Molecular pathology is revolutionising clinical practice in oncology and pathology paving the way for precision medicine, and has evolved into a growing research field. Knowledgeable molecular pathologists are a significant bottle neck for advancing cancer research and patient care.
This meeting will provide participants with a broad view of the scope, methodologies, future directions and challenges in addition to practical approaches for molecular pathology in research and in clinical settings. The potential uses of deep learning in pathology will be discussed. The meeting will help participants to establish a network of interactions and to build bridges to foster cross disciplinary studies. We are preparing for the future and for the unknown discoveries still to come.
This conference will be of interest to a diverse audience including pathologists, molecular pathologists and pathology residents, researchers in the field of molecular diagnostics and precision oncologists. The conference population will thus simulate the multidisciplinary teams that act in the real world to facilitate interdisciplinary research and the multidisciplinary teams caring for patients with cancer.
Scientific Programme Committee:
Follow us on twitter for updates @EACRnews and engage with the conference with #MolPath20
Accreditation by the European Accreditation Council for Continuing Medical Education (EACCME®) is being applied for.
Bursary application deadline:
13 March 2020
Abstract submission deadline:
13 March 2020
17 April 2020
“Great course and wonderful speakers, interesting and well organized!"
"It provides a comprehensive overview of the most important molecular patholgy findings per tumor type."
Feedback from 2018 participants
This is considered an out of date browser. This website has been developed with modern browsers in mind to allow it to display at its best in a wide variety of viewing situations - including mobile viewing. But we haven't supported older browsers like IE8. Please upgrade to the latest version of Internet Explorer - or try Mozilla Firefox or Google Chrome. Both are excellent browsers.